SEC Form 4 · accession 0001209191-17-063403
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel N Gregoire
Officer — General Counsel and Secretary
Period of report
Dec 1, 2017
Accepted (ET)
Dec 4, 2017 · 11:52 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par value | Dec 1, 2017 | X | 3,233 | $63.95 | A | 16,690 | D | |
| Ordinary Common Stock, $0.01 par value | Dec 1, 2017 | X | 5,042 | $64.87 | A | 21,732 | D | |
| Ordinary Common Stock, $0.01 par valueF2 | Dec 1, 2017 | S | 8,275 | $89.08 | D | 13,457 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F4,F3 | $63.95 | Dec 1, 2017 | X | 3,233 | D | — | Mar 4, 2025 | Common Stock | 3,233 | 12,538 | D |
| Stock Options (right to buy)F4,F5 | $64.87 | Dec 1, 2017 | X | 5,042 | D | — | Mar 3, 2026 | Common Stock | 5,042 | 10,083 | D |
Explanation of responses
- F1This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- F2The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $88.50 to $90.30, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- F3The remainder of 12,538 options shall vest on March 4, 2018.
- F4Not applicable.
- F5The remainder of 10,083 options shall vest in equal increments on March 3 of 2018 and 2019.